Identification of CACNA1A large deletions in four patients with episodic ataxia

Area of Science:

• Genetics
• Neurology
• Molecular Biology

Background:

• Episodic ataxia type 2 (EA2) is an autosomal dominant ion channel disorder.
• It is typically caused by mutations in the CACNA1A gene, often nonsense or missense mutations.
• However, some families with typical EA2 phenotypes lack detectable point mutations in CACNA1A.

Observation:

• A quantitative multiplex polymerase chain reaction (PCR) assay was developed to screen all 50 exons of the CACNA1A gene.
• Twenty-seven probands with suspected EA2, previously negative for point mutations, were investigated using this assay.
• Four distinct exonic deletions in CACNA1A were identified in four patients exhibiting a typical EA2 phenotype.

Findings:

• Exonic deletions represent a significant cause of EA2 in patients negative for point mutations.
• The developed PCR assay effectively detects these exonic deletions within the CACNA1A gene.
• This study highlights the necessity of including deletion screening in the molecular diagnostic workup for EA2.

Implications:

• Expanding molecular diagnostic strategies to include deletion analysis will improve the diagnostic yield for EA2.
• Accurate genetic diagnosis of EA2 is essential for genetic counseling and potential therapeutic strategies.
• Understanding the full spectrum of CACNA1A mutations provides deeper insights into ion channel function and neurological disorders.